Christian Grommes

Trials

Studies that name Christian Grommes as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 00:04 UTC. Open this list on ClinicalTrials.gov

• Ph1
  NCT07082868 · A Study of Epcoritamab and Ibrutinib in People With Central Nervous System Lymphoma (CNSL)

  Memorial Sloan Kettering Cancer Center · recruiting · Primary Central Nervous System Lymphoma (PCNSL), Primary Central Nervous System Lymphoma, Relapsed Primary Central Nervous System Lymphoma · principal investigator
• Ph2
  NCT04401774 · Nivolumab Maintenance in Newly Diagnosed PCNSL With Persistent CSF Circulating Tumor DNA After Completion of First-Line Chemotherapy

  Memorial Sloan Kettering Cancer Center · completed · Primary Central Nervous System Lymphoma (PCNSL) · principal investigator
• Ph2
  NCT03743662 · Nivolumab With Radiation Therapy and Bevacizumab for Recurrent MGMT Methylated Glioblastoma

  Memorial Sloan Kettering Cancer Center · active not recruiting · Glioblastoma · principal investigator
• Ph1
  NCT03703167 · Ibrutinib With Rituximab and Lenalidomide for Patients With Recurrent/Refractory Primary or Secondary Central Nervous System Lymphoma (PCNSL/SCNSL)

  Memorial Sloan Kettering Cancer Center · completed · Primary Central Nervous System Lymphoma (PCNSL), Secondary Central Nervous System Lymphoma (SCNSL) · principal investigator
• Ph1/Ph2
  NCT03581942 · Copanlisib With Ibrutinib for Patients With Recurrent/ Refractory Primary Central Nervous System Lymphoma (PCNSL)

  Memorial Sloan Kettering Cancer Center · completed · Refractory/Recurrent Primary Central Nervous System Lymphoma (PCNSL) · principal investigator
• Ph1/Ph2
  NCT02315326 · Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Patients With Newly Diagnosed or Refractory/Recurrent Primary Central Nervous System Lymphoma (PCNSL) and Refractory/Recurrent Secondary Central Nervous System Lymphoma (SCNSL)

  Memorial Sloan Kettering Cancer Center · completed · Adult Patients With Newly Diagnosed or Relapsed or Refractory Primary Central Nervous System Lymphoma (PCNSL), Or Relapsed or Refractory Secondary Central Nervous System Lymphoma (SCNSL) · principal investigator
• Ph2
  NCT02301364 · Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL)

  Memorial Sloan Kettering Cancer Center · completed · Lymphoma, Primary Central Nervous System Lymphoma, Recurrent/Refractory Secondary Central Nervous System Lymphoma · principal investigator
• Ph2
  NCT00596154 · Rituximab, Methotrexate, Procarbazine and Vincristine Followed by High-dose Chemotherapy With Autologous Stem-cell Rescue in Newly-diagnosed Primary CNS Lymphoma

  Memorial Sloan Kettering Cancer Center · completed · CNS Lymphoma, CNS Brain Cancer, Non-Hodgkin's Lymphoma · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 00:04 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.